2025
SJR Q1
JCR Q1 · 5
82 matched articles
SCIE
Journal detail
European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier B.V.
- Country
- Netherlands · Western Europe
- Type
- journal
- ISSN
-
0939641118733441
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,848
- Quartile Q1
- H-Index 201
- Cites/doc 5,26
- Docs (3y) 783
- Cites (3y) 4.093
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5
- 5Y JIF 5,1
- JCI 1,27
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biotechnology Q2
- Medicine (miscellaneous) Q2
- Pharmaceutical Science Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 0,848 | 5 | 5,1 | 1,27 | Q1 | 201 |
| 2024 | Q1 | Q1 | 0,905 | 4,3 | 4,8 | 1,4 | Q1 | 193 |
| 2023 | Q1 | Q1 | 0,835 | 4,4 | 4,8 | 1,41 | Q1 | 193 |
| 2022 | Q1 | Q1 | 0,83 | 4,9 | 5,3 | 1,51 | Q1 | 193 |
| 2021 | Q1 | Q1 | 0,857 | 5,6 | 6,1 | 1,48 | Q1 | 193 |
| 2020 | Q1 | Q1 | 1,103 | 5,6 | 6,1 | 1,63 | Q1 | 193 |
| 2019 | Q1 | Q1 | 1,059 | 4,6 | 4,9 | 1,65 | Q1 | 193 |
| 2018 | — | Q1 | — | 4,7 | 5,1 | 1,74 | Q1 | — |
| 2017 | Q1 | Q1 | 1,342 | 4,5 | 4,6 | 1,59 | Q1 | 193 |
| 2016 | Q1 | Q1 | 1,411 | 4,2 | 4,5 | — | — | 193 |
| 2015 | Q1 | Q1 | 1,437 | 4 | 4,4 | — | — | 193 |
| 2014 | Q1 | Q1 | 1,481 | 3,9 | 4,6 | — | — | 193 |
| 2013 | Q1 | Q1 | 1,566 | 4,2 | 4,7 | — | — | 193 |
| 2012 | Q1 | Q1 | 1,99 | 3,8 | 4,7 | — | — | 193 |
| 2011 | Q1 | Q1 | 1,799 | 4,3 | 4,4 | — | — | 193 |
| 2010 | Q1 | Q1 | 1,961 | 4,3 | 4,4 | — | — | 193 |
| 2009 | — | Q2 | — | 3,2 | 3,7 | — | — | — |
| 2008 | — | Q2 | — | 3,3 | 3,9 | — | — | — |
| 2007 | — | Q2 | — | 2,6 | 3,2 | — | — | — |
| 2006 | — | Q2 | — | 3,2 | — | — | — | — |
| 2005 | — | Q2 | — | 2,5 | — | — | — | — |
| 2004 | — | Q2 | — | 1,9 | — | — | — | — |
| 2003 | — | Q3 | — | 1,4 | — | — | — | — |
| 2002 | — | Q2 | — | 2,1 | — | — | — | — |
| 2001 | — | Q2 | — | 1,5 | — | — | — | — |
| 2000 | — | Q3 | — | 1,1 | — | — | — | — |
| 1999 | — | Q4 | — | 0,6 | — | — | — | — |
| 1998 | — | Q3 | — | 1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 70/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 69/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 65/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 61/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 60/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 48/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 40/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 28/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 28/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 43/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 45/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 49/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 30/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 49/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 37/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 37/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 70/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 56/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 73/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 50/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 60/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 90/187 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 110/185 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 59/188 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 83/186 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 110/181 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 138/175 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 100/178 |